Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines" (SUSTAIN)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00861081|
Recruitment Status : Completed
First Posted : March 13, 2009
Last Update Posted : June 5, 2018
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Behavioral: Care Management Behavioral: Written Materials||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||410 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Health Services Research|
|Official Title:||RCT of an Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines" (SUSTAIN)|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||September 2013|
|Actual Study Completion Date :||September 2013|
|Experimental: 1: Care management||
Behavioral: Care Management
Over a period of one year, subjects will participate in two regular stroke clinics, three group clinics, obtain self-management tools, and will receive a series of four scheduled telephone calls by nurse practitioners to review information delivered during the group clinics and help with care coordination. Usual care will also be available.
|Active Comparator: 2: Written Materials||
Behavioral: Written Materials
Educational materials about stroke that will be distributed during the group clinic session will be mailed to these subjects. These materials have been developed by the American Heart Association. Usual care will also be available.
- Blood Pressure [ Time Frame: 12 months ]Blood pressure at 12 months will be the primary outcome. Blood pressure will also be measured at baseline and at the 3-month mark to track blood pressure during the entire participation period.
- Lipid levels [ Time Frame: 12 month ]LDL, HDL, triglycerides and total cholesterol will be measured at 12-months. The same measurements will be taken at baseline and at the 3 month mark in order to track measurements throughout the entire participation period.
- Medication Adherence [ Time Frame: 8 months ]Medication adherence will be measured in a self-report by the subjects.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00861081
|United States, California|
|Rancho Los Amigos National Rehabilitation Center|
|Downey, California, United States, 90242|
|Los Angeles, California, United States, 90024|
|LAC+USC Medical Center|
|Los Angeles, California, United States, 90033|
|Olive View-UCLA Medical Center|
|Sylmar, California, United States, 91342|
|Harbor-UCLA Medical Center|
|Torrance, California, United States, 90502|
|Principal Investigator:||Barbara Vickrey, MD, MPH||University of California, Los Angeles|